Stock listing

OTC:SCPS Scopus BioPharma, Inc. Stock

Follow Scopus BioPharma, Inc. into a list and get an email when it puts out news.

Share price · OTC:SCPS

$0.0004 USD 0.0000 (0.0%)

Close on Oct 26, 2026

Past year +33.3% · daily closes, Oct 27, 2025 – Oct 26, 2026, adjusted for splits
Day range
$0.0004 – $0.0004 USDOct 26, 2026
Volume
1,800 sharesOct 26, 2026
Market cap
$16,834 USDAt the close on Oct 26, 2026 · price × 42.08M shares outstanding
52-week range
$0.0003 – $0.0100 USDLowest and highest trades, Oct 27, 2025 – Oct 26, 2026
Traded on an average day
$2 USDMedian day 0 shares · 33 days with no trades · last 3 months, Jul 27, 2026 – Oct 26, 2026
Scopus BioPharma, Inc. logo

Daily closes

Last 3 months, Jul 27, 2026 – Oct 26, 2026 · OTC:SCPS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00040.00000.0%$0.0004$0.0004$0.00041,800
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.0004150,025
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.0004100
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.0004385
$0.00040.00000.0%$0.0004$0.0004$0.0004150
$0.0004-0.0002-33.3%$0.0004$0.0004$0.00041,000
$0.0006+0.0002+50.0%$0.0006$0.0006$0.0006269
$0.00040.00000.0%$0.0004$0.0004$0.00042,000
$0.00040.00000.0%$0.0004$0.0004$0.0004501
$0.00040.00000.0%$0.0004$0.0004$0.0004448
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.0004-0.0002-33.3%$0.0004$0.0004$0.000432,052
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00065,002
$0.0006+0.0002+50.0%$0.0006$0.0006$0.00062,824
$0.00040.00000.0%$0.0004$0.0004$0.0004500
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.000447,076
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00041,199
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.0004200
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.0004489
$0.00040.00000.0%$0.0004$0.0004$0.00041,100
$0.00040.00000.0%$0.0004$0.0004$0.0004134
$0.00040.00000.0%$0.0004$0.0004$0.00045,901
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00041,468
$0.00040.00000.0%$0.0004$0.0004$0.0004123
$0.00040.00000.0%$0.0004$0.0004$0.0004125
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00043,000
$0.0004-0.0001-20.0%$0.0004$0.0004$0.0004580
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
Ticker
OTC:SCPS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

All Scopus BioPharma, Inc. news

Scopus BioPharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in all · newest Nov 7, 2023 · oldest 2022
Decks
10 decks · latest Mar 23, 2022

Valuation

price Oct 26, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
1.32

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Scopus BioPharma, Inc. · OTC:SCPSUS$16,834n/an/an/an/an/an/an/a1.32
Vaxil Bio Ltd. · TSXV:VXLUS$319,500−US$4,0701.2×n/an/a0.4×n/a0.0×-0.16
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
CNBX Pharmaceuticals Inc. · OTC:CNBXUS$160,577US$151,090n/an/an/an/an/an/a1.78
Fifty 1 Labs Inc. · OTC:FITYUS$118,532US$282,021n/a6,000×n/an/an/an/a-1.17
GB Sciences, Inc. · OTC:GBLXUS$81,414US$2.07Mn/an/an/an/an/an/a-0.46
Lyra Therapeutics, Inc. · OTC:LYRAUS$53,246US$14.42Mn/a36.2×n/an/an/an/a0.67
Median of the othersUS$192,289US$73,5101.2×18.5×0.2×−382.1%0.0×1.14

Events

QuarterResultsShare move
Quarter to Dec 31, 2025Feb 25, 20260.0%
Quarter to Sep 30, 2025Dec 3, 2025+25.0%
Quarter to Jun 30, 2025Sep 3, 20250.0%
Quarter to Mar 31, 2025May 28, 20250.0%
Quarter to Dec 31, 2024Feb 26, 20250.0%
Quarter to Sep 30, 2024Nov 27, 20240.0%
Quarter to Jun 30, 2024Aug 28, 20240.0%
Quarter to Mar 31, 2024May 29, 2024−90.5%
Quarter to Dec 31, 2023Feb 28, 2024+5.0%
Quarter to Sep 30, 2023Nov 29, 2023−11.9%
All 20 quarters
QuarterResultsShare move
Q2 2023Aug 11, 2023 · After close−37.1%
Q1 2023May 12, 2023 · After close0.0%
Q4 2022Mar 1, 2023−6.3%
Q3 2022Nov 21, 2022−16.8%
Q2 2022Aug 31, 2022−5.7%
Q1 2022Apr 15, 2022 · After close−5.9%
Q4 2021Mar 2, 2022−3.9%
Q3 2021Nov 12, 2021 · After close+0.9%
Q2 2021Aug 13, 2021 · After close−6.2%
Q1 2021May 17, 2021 · After close−2.6%

Open Events

Decks

DeckKindSlidesDate
STING & TLR-Targeting Therapies Summit 2022Conference18 slidesMar 23, 2022
Corporate Update (September 2021)Corporate update21 slidesSep 13, 2021
Investor Presentation (September 2021)Investor deck21 slidesSeptember 2021
Investor Presentation (January 2021)Investor deck21 slidesJan 20, 2021
Investor Presentation (January 2021)Investor deck19 slidesJanuary 2021
Investor Presentation (December 2020)Investor deck19 slidesDecember 2020
IPO Roadshow (September 2020)IPO roadshow33 slidesSeptember 2020
Investor Presentation (September 2020)Investor deck29 slidesSeptember 2020
IPO Roadshow (October 2019)IPO roadshow16 slidesOct 2, 2019
IPO Roadshow (September 2019)IPO roadshow15 slidesSep 27, 2019

Open Decks

Financials

Annual, in USD

Income statement

LineFY2022FY2021FY2020FY2019FY2018FY2017
Revenue00000
Research and development2.68M15.0M7.42M463.1K277.5K
Selling, general and administrative9.03M12.6M2.73M2.23M408.4K
Operating income-11.7M-27.6M-10.2M-2.69M-686.0K
Depreciation and amortization1.73K1.50K1.44K664664664
EBITDA-11.7M-27.6M-10.2M-2.69M-685.3K
Interest expense0774.7K706.4K000
Income before tax-11.7M-27.0M-10.9M-2.69M-686.0K
Income tax-105.0K-1.46M706.4K1
Net income-11.6M-25.5M-11.6M-2.69M-686.0K
Earnings per share, basic-0.55-1.48-0.87-0.18-0.05

Balance sheet

LineFY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents124.6K7.94M1.83M36.7K1.66K158.2K
Receivables56227.9K54.7K
Inventory730.7K
Current assets390.0K8.18M1.97M768.0K132.6K212.9K
Property, plant and equipment2.27K2.84K2.33K3.66K
Total assets392.3K8.19M1.97M771.7K132.6K212.9K
Accounts payable175.6K116.1K1.52M163.1K
Current liabilities7.45M4.17M3.81M854.5K138.0K111.3K
Total debt2.28M
Total liabilities7.45M4.17M3.81M854.5K138.0K111.3K
Shareholders' equity-7.06M4.02M-1.83M-82.9K-5.33K101.6K
Shares outstanding21.1M17.3M13.4M15.0M15.0M15.0M

Cash flow

LineFY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-8.13M-11.4M-2.53M-2.12M-747.3K-228.4K
Capital spending-1.55K-2.00K-2.00K-4.25K-4.25K-4.25K
Free cash flow-8.13M-11.4M-2.53M-2.12M-747.3K-232.6K
Cash from investing-1.55K-2.00K-2.00K-4.25K-4.25K-4.25K
Cash from financing241.9K17.6M4.35M2.18M597.6K465.7K
Change in cash-7.82M6.11M1.80M35.1K-156.6K237.3K

Open Financials

Cap table

Built by 6ix from Scopus BioPharma, Inc.’s releases

Common shares
42,084,264
Fully diluted
42,084,264

Fully diluted

LineShares
Common shares42,084,264

Share count over time

CountShares
Nov 22, 202642,084,264

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Weild IV
Other companies: High Roller Technologies, Inc. (Director · Since at least Oct 23, 2024); PAVmed Inc. (Director · Feb 14, 2018 – Apr 1, 2021 · Past); Streamex Corp. (Director · Nov 24, 2017 – Aug 15, 2023 · Past)
Director · Dec 16, 2020 – Dec 16, 2020 · Past
David S Battleman
Other companies: Lipella Pharmaceuticals, Inc. (Director · Dec 19, 2022 – Jun 16, 2023 · Past); PAVmed Inc. (Director · Aug 3, 2017 – Apr 1, 2021 · Past)
Director · Dec 16, 2020 – Dec 16, 2020 · Past
David A Buckel
Other companies: SharpSpring Inc (Director · Jan 13, 2014 – Sep 1, 2021 · Past)
Director · Dec 16, 2020 – Dec 16, 2020 · Past
Raphael Hofstein
Other companies: BioLineRX Ltd. (Director · Since at least Mar 18, 2026)
Director · Dec 16, 2020 – Dec 16, 2020 · Past
Robert J GibsonVice Chairman, Director · Dec 15, 2020 – Feb 24, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Scopus BioPharma, Inc.